<b>Optimizing a Single Monthly Dose of Risedronate Based on its Weekly Dose in Healthy Japanese Postmenopausal Women </b>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Optimizing a Single Monthly Dose of Risedronate Based on its Weekly Dose in Healthy Japanese Postmenopausal Women

Published:2017 Issue:4 Volume:48 Page:121-129
ISSN:0388-1601
Container-title:Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics
language:en
Short-container-title:Jpn. J. Clin. Pharmacol. Ther.

Author:

NAGASHIMA Hirotaka¹²,HIRAYAMA Masashi³⁴,OHISHI Hiroaki⁵,OIKAWA Ichiro⁵

Affiliation:

1. Department of Cardiology, Tokyo Heart Center, Ohsaki Hospital

2. Shinjuku Research Park Clinic

3. Clinical Data Science, Takeda Development Center Japan, Takeda Pharmaceutical Company Limited

4. Development Management, Takeda Development Center Japan, Takeda Pharmaceutical Company Limited

5. Clinical Development Dept., EA Pharma Co., Ltd.

Publisher

Japanese Society of Clinical Pharmacology and Therapeutics

Subject

Pharmacology (medical),Pharmacology

Link

https://www.jstage.jst.go.jp/article/jscpt/48/4/48_121/_pdf

Reference18 articles.

1. 1) Russell RG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008; 19(6) : 733-59. doi: 10.1007/s00198-007-0540-8.

2. 2) Reid DM, Hughes RA, Laan RF, Sacco-Gibson NA, Wenderoth DH, Adami S, et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J Bone Miner Res. 2000; 15(6): 1006-13. doi: 10.1359/jbmr.2000.15.6.1006.

3. 3) Hooper MJ, Ebeling PR, Roberts AP, Graham JJ, Nicholson GC, D'Emden M, et al. Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial. Climacteric. 2005; 8(3): 251-62. doi: 10.1080/13697130500118126.

4. 4) Gatti D, Adami S. New bisphosphonates in the treatment of bone diseases. Drugs Aging. 1999; 15(4): 285-96.

5. 5) Umland EM, Boyce EG. Risedronate: a new oral bisphosphonate. Clin Ther. 2001; 23(9): 1409-21.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3